I don’t have live access right now to fetch up-to-the-minute news, but I can summarize what’s circulating recently about orphines and point you toward credible sources.
- The NYT article from May 2026 describes orphines as a new class of highly potent synthetic opioids appearing in street drugs, with higher danger than fentanyl and spreading across multiple states. It notes limited current prevalence but rising concern among public health and law enforcement.[5]
- Public and health outlets have reported ongoing alerts about orphines, including detection in toxicology screenings becoming a concern for emergency responders and policymakers aiming to update testing protocols.[6][5]
- Coverage from financial and pharmaceutical news outlets has occasionally referenced orphines in broader discussions of illicit-drug markets and regulatory responses, though this class is primarily discussed in health and safety contexts rather than as a commercial drug candidate.[4][9]
If you want, I can:
- Narrow to a specific region (e.g., Brazil, the U.S. South) and fetch the latest regional bulletins.
- Pull peer-reviewed or government sources (CDC, DEA) for authoritative risk assessments and recommended precautions.
- Set up a quick alert plan (keywords to monitor) so you get updates as they’re published.
Would you like me to focus on a particular region or type of source (government, media, or academic)? I can also provide a concise list of current official advisories and recommended safety steps.
Citations:
- New York Times overview of orphines as a new dangerous opioid class.[5]
- Public health and safety discussions and detection concerns around orphines.[6][5]
Sources
One of the newest and most concerning orphines is N-propionitrile chlorphine. It was first detected in mid-2024 by the Center for Forensic Science Research and Education (CFSRE). Lab studies show it is about 10 times stronger than fentanyl. Since mid-2025, it has been found more often in fatal overdoses. … The data, coming from cases in nine states in the U.S. and 3 Canadian provinces, is alarming.^^ 25 fatal overdoses tested at CFSRE contained N-propionitrile chlorphine. Most occurred in late...
drugfree.orgShould You Buy or Sell Orphazyme A/S Stock? Get The Latest ORPH Stock Analysis, Price Target, Headlines, and Short Interest at MarketBeat.
www.marketbeat.comorphan Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. orphan Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comOrphazyme A/S (ORPH) Latest News & Updates – Why is it moving? What’s happening today? Get real-time market sentiment and stock updates
public.comorphans Latest Breaking News, Pictures, Videos, and Special Reports from The Economic Times. orphans Blogs, Comments and Archive News on Economictimes.com
economictimes.indiatimes.comFunding to support preclinical development of Orphagen’s lead IBD candidate, OR-812, a first-in-class, small molecule inhibitor of the retinoic acid receptor alpha (RARα) SAN DIEGO--(BUSINESS WIRE)--Orphagen Pharmaceuticals, Inc., a biotech company pioneering the... The Cancer Prevention & Research Institute of Texas (CPRIT) announced today that it plans to award Orphagen a $10.2 M product development grant over three years to partially fund the final steps towards IND filing and a Phase 1...
www.orphagen.comThe drugs are 10 times more dangerous than fentanyl. They are showing up in street drugs in the South and the Midwest, and will most likely spread to other regions.
www.nytimes.comWhat's going on at Orphazyme A/S (NASDAQ:ORPH)? Read today's ORPH news from trusted media outlets at MarketBeat.
www.marketbeat.comFind Orphan Latest News, Videos & Pictures on Orphan and see latest updates, news, information from NDTV.COM. Explore more on Orphan.
www.ndtv.comOrphazyme A/S (ORPH) Latest News & Updates – Why is it moving? What’s happening today? Get real-time market sentiment and stock updates
public.com